Loading…
Formulation and Characterization of Glutaraldehyde Cross-Linked Chitosan Biodegradable Microspheres Loaded with Famotidine
Purpose: To formulate biodegradable chitosan microspheres loaded with famotidine to overcome the poor bioavailability and frequent dose administration of the drug. Methods: Chitosan microspheres were prepared by simple emulsification technique based on glutaraldehyde crosslinking. Various process an...
Saved in:
Published in: | Tropical journal of pharmaceutical research 2011-06, Vol.10 (3) |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Purpose: To formulate biodegradable chitosan microspheres loaded with
famotidine to overcome the poor bioavailability and frequent dose
administration of the drug. Methods: Chitosan microspheres were
prepared by simple emulsification technique based on glutaraldehyde
crosslinking. Various process and formulation variables such as speed
of emulsification, crosslinking time, drug/polymer ratio, volume of
cross linking agent and volume of surfactant were optimized. The
microspheres were characterized for entrapment efficiency, drug
loading, in vitro drug release, surface morphology, as well as by
particle size analysis, Fourier transform infrared (FTIR) spectroscopy
and differential scanning calorimetry (DSC). Results: The
microspheres showed a smooth surface with a narrow particle size
distribution (105 - 219 µm) and an entrapment efficiency of up to
73 %. They exhibited controlled drug release characteristics with 85.6
% of the drug released over a period of 24 h with an initial burst
release of 26.9 % in the first 2 h. Drug release followed Higuchi
release kinetics. FTIR and DSC data indicate that there was no drug
interaction between the drug and polymer used. Conclusion: The
chitosan microspheres could be further developed as a potential
biodegradable carrier for oral controlled delivery of famotidine. |
---|---|
ISSN: | 1596-5996 1596-9827 |
DOI: | 10.4314/tjpr.v10i3.13 |